Evaluation of systemic and mucosal immune responses in mice administered with recombinant Salmonella Typhimurium expressing IutA protein

  • Oh, In-Gyeong (College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) ;
  • Choi, Minsu (College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) ;
  • Lee, John Hwa (College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University)
  • Received : 2013.01.04
  • Accepted : 2013.07.16
  • Published : 2013.09.30


Avian pathogenic Escherichia coli (APEC) are known to cause extraintestinal disease in poultry, leading to substantial losses in the industry. IutA, iron-regulated aerobactin receptor is firmly associated with APEC. To assess the potential of IutA to induce protective immune responses, attenuated Salmonella Typhimurium strain expressing IutA was constructed and administered orally to BALB/c mice. The IutA-specific immune responses were measured with sera, vaginal and fecal samples by an enzyme-linked immunosorbent assay. We found that the Salmonella-IutA vaccine induced significantly higher immune responses as compared to the control inoculated with the attenuated S. Typhimurium containing the plasmid only. The IutA-specific immune responses were increased by second immunization at third week after initial immunization, whereas triple immunization induced lower immune responses than those induced by the double immunization. The Salmonella-IutA vaccine induced a nature of immunity biased to the Th1-type, as judged by the ratio of IutA-specific IgG isotypes (IgG2a/IgG1). Overall, these results suggest that the Salmonella-IutA vaccine appear to be suitable candidate for a vaccine against APEC.


Supported by : National Research Foundation (NRF)


  1. Altekruse SF, Elvinger F, Lee KY, Tollefson LK, Pierson EW, Eifert J, Sriranganathan N. Antimicrobial susceptibilities of Escherichia coli strains from a turkey operation. J Am Vet Med Assoc 2002, 221, 411-416.
  2. Delicato ER, de Brito BG, Gaziri LCJ, Vidotto MC. Virulence-associated genes in Escherichia coli isolates from poultry with colibacillosis. Vet Microbiol 2003, 94, 97-103.
  3. de Lorenzo V, Bindereif A, Paw BH, Neilands JB. Aerobactin biosynthesis and transport genes of plasmid ColV-K30 in Escherichia coli K-12. J Bacteriol 1986, 165, 570-578.
  4. Ewers C, Janssen T, Kießling S, Philipp HC, Wieler LH. Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry. Vet Microbiol 2004, 104, 91-101.
  5. Graham MB, Braciale VL, Braciale TJ. Influenza virusspecific $CD4^+$ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994, 180, 1273-1282.
  6. Gulig PA, Curtiss R 3rd. Plasmid-associated virulence of Salmonella typhimurium. Infect Immun 1987, 55, 2891-2901.
  7. Kang HY, Srinivasan J, Curtiss R 3rd. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect Immun 2002, 70, 1739-1749.
  8. Kariywasam S, Wilkie BN, Gyles CL. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies. Vet Microbiol 2004, 98, 273-284.
  9. Kim TE, Jeong YW, Cho SH, Kim SJ, Kwon HJ. Chronological study of antibiotic resistances and their relevant genes in Korean avian pathogenic Escherichia coli isolates. J Clin Micorbiol 2007, 45, 3309-3315.
  10. Kwaga JKP, Allan BJ, van den Hurk JV, Seida H, Potter AA. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in Turkeys. Infect Immun 1994, 62, 3766-3772.
  11. Lafont JP, Dho M, D'Hauteville HM, Bree A, Sansonetti PJ. Presence and expression of aerobactin genes in virulent avian strains of Escherichia coli. Infect Immun 1987, 55, 193-197.
  12. Ons E, Bleyen N, Tuntufye HN, Vandemaele F, Goddeeris BM. High prevalence iron receptor genes of avian pathogenic Escherichia coli. Avian Pathol 2007, 36, 411-414.
  13. Peighambari SM, Hunter DB, Shewen PE, Gyles CL. Safety, immunogenicity, and efficacy of two Escherichia coli cya crp mutants as vaccines for broilers. Avian Dis 2002, 46, 287-297.[0287:SIAEOT]2.0.CO;2
  14. Ramasamy R, Yasawardena S, Zomer A, Venema G, Kok J, Leenhouts K. Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 2006, 24, 3900-3908.
  15. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Nolan LK. Characterizing the APEC pathotype. Vet Res 2005, 36, 241-256.
  16. Roland K, Karaca K, Sizemore D. Expression of Escherichia coli antigens in Salmonella typhimurium as a vaccine to prevent airsacculitis in chickens. Avian Dis 2004, 48, 595-605.
  17. Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR, Vitetta ES. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988, 334, 225-258.
  18. Strindelius L, Filler M, Sjöholm I. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Vaccine 2004, 22, 3797-3808.
  19. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991, 254, 277-279.
  20. Yoon HA, Aleyas AG, George JA, Park SO, Han YW, Hyun BH, Lee JH, Song HJ, Cho JG, Eo SK. Correlation between the nature of immunity induced by different immunogens and the establishment of latent infection by wild-type pseudorabies virus. Res Vet Sci 2007, 83, 73-81.
  21. Vandekerchove D, Vandemaele F, Adriaensen C, Zaleska M, Hernalsteens JP, De Baets L, Butaye P, Van Immerseel F, Wattiau P, Laevens H, Mast J, Goddeeris B, Pasmans F. Virulence-associated traits in avian Escherichia coli: comparison between isolates from colibacillosisaffected and clinically healthy layer flocks. Vet Microbiol 2005, 108, 75-87.
  22. Zhao X, Zhang M, Li Z, Frankel FR. Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag. J Virol 2006, 80, 8880-8890.